ARTICLE | Clinical News
Neurotrophin-3: Pilot
May 24, 1999 7:00 AM UTC
NT-3, given subcutaneously three times per week, relieved constipation symptoms in 8 of 10 patients. The product is being developed by Amgen-Regeneron Partners. Data were presented at the American Gas...